DalCor Pharma and Canada’s unsung life-sciences boom


DNA
Photo of scientists assessing DNA sequence ©iStock/poba
High-profile software financings in Canada have recently grabbed headlines, but a major surge of investment in life-sciences startups has gone mostly unnoticed. Fueled by improved fundraising and exit trends, venture investment in Canadian biotech, pharmaceuticals, medical diagnostics and other life-sciences ...

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.